Policy1h ago
FDA Grants Dexcom Medicare Reimbursement Pilot
The FDA selected Dexcom as the first company to join its TEMPO pilot program. This decision allows seniors to receive Medicare reimbursement for care delivered via the company's software. It establishes a concrete regulatory pathway for health tech software to monetize directly through federal insurance. Practitioners should monitor this for future medical AI billing.